小剂量阿糖胞苷治疗急性非淋巴细胞白血病11例疗效分析  

Clinical Analysis of Treating 11 Cases of Acute Nonlymphocytie Leukemia With Low Dose Ara-c

作　　者：李惠民[1] 陈黎[2] 梁瑞琼[2] 

机构地区：[1]昆明医学院附一院血液科 [2]昆明医学院

出　　处：《昆明医学院学报》1990年第3期55-56,60,共3页Journal of Kunming Medical College

摘　　要：本文报道了小剂量阿糖胞苷治疗11例不适宜于强烈化疗的急性非淋巴细胞白血病。1例完全缓解,1例部分缓解,缓解率为18.2%,并讨论了小剂量阿糖胞苷的疗效机理,副作用及缓解率。认为小剂量阿糖胞苷对于不宜于强烈化疗的病人仍不失为一积极的化疗选择。In this paper, acute nonlyumphocytic leukemia that is not fit for strong chemotherapy treated with low dose cytosine arabinoside (Ara—c) in 11 cases is presented. One of the patients got a complete remission and another was partial remiss, the total remission rate being 18.2%. The therapeutic mechanism, side effect, and remission rate of low dose Ara-c have been discussed. The authors conclude that this treatment is still of choice to the patients who are not fit for strong chemotherapy.

关 键 词：急性白血病 阿糖胞苷 疗效 

分 类 号：R733.710.5[医药卫生—肿瘤]